Xiaoping Ma
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Protein Kinase Regulation and GTPase Signaling
- RNA modifications and cancer
- Lipid Membrane Structure and Behavior
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 6
- Cancer-related gene regulation 5
- Epigenetics and DNA Methylation 5
- Circular RNAs in diseases 4
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- John F. Hancock (5 shared papers)Dharini van der Hoeven (5 shared papers)Kwang-Jin Cho (2 shared papers)Sravanthi Chigurupati (1 shared paper)Robert G. Parton (1 shared paper)Yong Zhou (2 shared papers)Yu Wu (4 shared papers)John D. Ng (1 shared paper)
- Journals
- Frontiers in Genetics (3 papers)Molecular and Cellular Biology (3 papers)Current Cancer Drug Targets (2 papers)Breast Cancer Targets and Therapy (1 paper)Parasitology Research (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaoping Ma
51 papers receiving 837 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 210
- Molecular Biology 489
- Cell Biology 116
- Ophthalmology 64
- Oncology 105
Countries citing papers authored by Xiaoping Ma
This map shows the geographic impact of Xiaoping Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Ma more than expected).
Fields of papers citing papers by Xiaoping Ma
This network shows the impact of papers produced by Xiaoping Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Ma. The network helps show where Xiaoping Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 85 | |
| 2 | 2015 | 83 | |
| 3 | 2014 | 40 | |
| 4 | 2017 | 39 | |
| 5 | 2020 | 37 | |
| 6 | 2014 | 37 | |
| 7 | 2016 | 32 | |
| 8 | 2019 | 30 | |
| 9 | 2018 | 29 | |
| 10 | 2009 | 29 | |
| 11 | 2021 | 26 | |
| 12 | 2014 | 26 | |
| 13 | 2024 | 25 | |
| 14 | 2015 | 22 | |
| 15 | 2015 | 21 | |
| 16 | 2018 | 21 | |
| 17 | 2011 | 19 | |
| 18 | 2018 | 17 | |
| 19 | 2013 | 17 | |
| 20 | Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells. | 2015 | 17 |
About Xiaoping Ma
Xiaoping Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Genetics, having authored 55 papers that have together received 847 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers), Epigenetics and DNA Methylation (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Cells and Metastasis (4 papers), Circular RNAs in diseases (4 papers), Ocular Surface and Contact Lens (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (210 citations), Molecular Biology (489 citations), Cell Biology (116 citations), Ophthalmology (64 citations) and Oncology (105 citations). Xiaoping Ma has collaborated with scholars based in China, United States and Australia. Frequent co-authors include John F. Hancock, Dharini van der Hoeven, Kwang-Jin Cho, Sravanthi Chigurupati, Robert G. Parton, Yong Zhou, Yu Wu, John D. Ng, Wei Chen and Masashi Maekawa. Their work appears in journals such as Frontiers in Genetics, Molecular and Cellular Biology, Current Cancer Drug Targets, Breast Cancer Targets and Therapy and Parasitology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.